PharmaCyte Biotech Inc (PMCB)

[Triple9]

from Facebook:

Question: "Is Pharmacyte still planning on following through with their statement of starting pivotal clinical trial for pancreatic cancer in q4 of this year?"

Answer: "We have no new updates regarding this. We are working on all the items the FDA requires from us to include in the IND. The rate-limiting factor, as mentioned in our published interview with Sarah DeMare of Facet Life Sciences (http://pharmacyte.com/pharmacyte-biotech-updates-ind.../), is the growth of the cells. We have no way of predicting how long this will take and thus can only say that we're working on all of the items that the FDA requires from us to include in the IND. We will submit the IND when we have all of the required information. Once we submit the IND and have FDA approval to proceed with the clinical trial, then we will be able to develop and release a timeline to the public. Thank you for your patience throughout this process!"

https://www.facebook.com/pharmacytebiotech/